Biotech startups in Boulder, United States
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Arpeggio Bio | Boulder | Series A | $20.0M | 2025-11-19 |
| Ambrosia Biosciences | Boulder | Series B | $100.0M | 2026-03-31 |
| Think Bioscience | Boulder | Series A | $55.0M | 2026-01-20 |
| BioLoomics | Boulder | Seed | $8.7M | 2023-09-19 |
4 rows of the CSV in 5 of its 18 columns.
- The 23 biotech startups in Boulder, United States have raised $1.5B in total.
- 5 of them closed their most recent round in the last 12 months, $490.5M combined.
- The largest of those rounds is Enveda's $311.0M Series E, dated September 2026.
- Innovation Endeavors is an investor in 2 of them, more than any other fund.
- Health care is the most common other sector, with 18 companies (78%).
- 26% were founded in 2020 or later; the median founding year is 2017.
- The most common team size is 1 to 10 employees (43% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
4 of 23| Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|
| Ambrosia Biosciences | Ambrosia Biosciences provides drug development services for small molecule therapies targeting obesity and metabolic disorders. | Biotech | Series B | $100.0M | 2026-03-31 | $141.0M | Boulder Ventures, Biotechnology Value Fund | 11 to 50 | 2024 |
| Think Bioscience | Think Bioscience designs and assembles medicines using living systems through synthetic biology. | Biotech | Series A | $55.0M | 2026-01-20 | $78.3M | National Science Foundation, Innovation Endeavors, Wireframe Ventures +2 | 11 to 50 | 2019 |
| Arpeggio Bio | Arpeggio Bio builds technology that observes how drugs work. | Artificial intelligence | Series A | $20.0M | 2025-11-19 | $40.4M | Y Combinator, Khosla Ventures, FundersClub +1 | 11 to 50 | 2017 |
| BioLoomics | BioLoomics is a biotechnology company that develops antibodies for cancer therapies. | Biotech | Seed | $8.7M | 2023-09-19 | $10.1M | Horizons Ventures, Innovation Endeavors, Hummingbird Ventures +2 | 11 to 50 | 2019 |
Table 1. Biotech startups in Boulder, United States: the 4 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 23.
Largest rounds
Last 12 months| # | Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Ambrosia Biosciences | Ambrosia Biosciences provides drug development services for small molecule therapies targeting obesity and metabolic disorders. | Biotech | Series B | $100.0M | 2026-03-31 | $141.0M | Boulder Ventures, Biotechnology Value Fund | 11 to 50 | 2024 |
| 2 | Think Bioscience | Think Bioscience designs and assembles medicines using living systems through synthetic biology. | Biotech | Series A | $55.0M | 2026-01-20 | $78.3M | National Science Foundation, Innovation Endeavors, Wireframe Ventures +2 | 11 to 50 | 2019 |
| 3 | Arpeggio Bio | Arpeggio Bio builds technology that observes how drugs work. | Artificial intelligence | Series A | $20.0M | 2025-11-19 | $40.4M | Y Combinator, Khosla Ventures, FundersClub +1 | 11 to 50 | 2017 |
Table 2. Biotech startups in Boulder, United States: the 3 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Innovation Endeavors | Venture capital firm | Palo Alto, United States | 2 | 9% | 1 | Think Bioscience |
| 2 | FundersClub | Micro VC fund | San Francisco, United States | 1 | 4% | 1 | Arpeggio Bio |
| 3 | Y Combinator | Startup accelerator | Mountain View, United States | 1 | 4% | 1 | Arpeggio Bio |
| 4 | Khosla Ventures | Venture capital firm | Menlo Park, United States | 1 | 4% | 1 | Arpeggio Bio |
| 5 | Builders VC | Venture capital firm | San Francisco, United States | 1 | 4% | 1 | Arpeggio Bio |
| 6 | Boulder Ventures | Venture capital firm | Boulder, United States | 1 | 4% | 1 | Ambrosia Biosciences |
| 7 | Biotechnology Value Fund | Venture capital firm | San Francisco, United States | 1 | 4% | 1 | Ambrosia Biosciences |
| 8 | National Science Foundation | Entrepreneurship program | Alexandria, United States | 1 | 4% | 1 | Think Bioscience |
| 9 | Xora Innovation | Venture capital firm | Singapore | 1 | 4% | 1 | Think Bioscience |
| 10 | Wireframe Ventures | Venture capital firm | Mill Valley, United States | 1 | 4% | 1 | Think Bioscience |
| 11 | AV8 Ventures | Venture capital firm | Palo Alto, United States | 1 | 4% | 1 | Think Bioscience |
| 12 | Hummingbird Ventures | Venture capital firm | Brussels, Belgium | 1 | 4% | ||
| 13 | Horizons Ventures | Venture capital firm | Hong Kong | 1 | 4% | ||
| 14 | Boom Capital Ventures | Venture capital firm | San Francisco, United States | 1 | 4% | ||
| 15 | TechU Ventures | Venture capital firm | New York, United States | 1 | 4% |
Table 3. Biotech startups in Boulder, United States: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Health care | 18 | 78% | $1.4B |
| Software | 5 | 22% | $881.8M |
| Artificial intelligence | 3 | 13% | $881.8M |
| Hardware | 3 | 13% | $69.6M |
| Commerce | 1 | 4% | |
| Energy | 1 | 4% | $63.6M |
Table 4. Biotech startups in Boulder, United States by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Pre-seed | 1 | 4% | $500K |
| Seed | 10 | 43% | $500K |
| Series A | 3 | 13% | $40.0M |
| Series B | 5 | 22% | $17.2M |
| Series C | 3 | 13% | $36.5M |
| Series D+ | 1 | 4% | $311.0M |
Table 5. Biotech startups in Boulder, United States by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| September 2026 | 1 | 20% | $311.0M |
| August 2026 | 1 | 20% | $4.5M |
| March 2026 | 1 | 20% | $100.0M |
| January 2026 | 1 | 20% | $55.0M |
| November 2025 | 1 | 20% | $20.0M |
Table 6. Biotech startups in Boulder, United States: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 4 | 17% | $470.5M |
| 2025 | 4 | 17% | $37.8M |
| 2024 | 2 | 9% | $150K |
| 2023 | 2 | 9% | $17.7M |
| 2022 | 1 | 4% | $40.0M |
| 2021 | 1 | 4% |
Table 7. Biotech startups in Boulder, United States by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 5 | 22% |
| 2020 to 2022 | 1 | 4% |
| 2015 to 2019 | 11 | 48% |
| 2010 to 2014 | 3 | 13% |
| Before 2010 | 3 | 13% |
Table 8. Biotech startups in Boulder, United States by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 10 | 43% |
| 11 to 50 | 7 | 30% |
| 51 to 100 | 4 | 17% |
| 101 to 250 | 1 | 4% |
| 251 to 500 | 1 | 4% |
Table 9. Biotech startups in Boulder, United States by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Biotech is one of its sectors and its headquarters is in Boulder, United States. On 16 November 2026 that is 23 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 4 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 23 rows: 4 have no round amount, 0 no city and 5 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many biotech startups in Boulder, United States are on the list?
- 23, in the file dated 16 November 2026. 5 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 23 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.